IMARC Group's report titled "Neurotechnology Market Report by Product Type (Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants), End User (Hospitals, Clinics, Diagnostic Centres, Ambulatory Surgical Centres), and Region 2024-2032". The global neurotechnology market size reached US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.54% during 2024-2032.

Factors Affecting the Growth of the Neurotechnology Industry:

  • Advancements in Neuroscience and Technology:

Ongoing breakthroughs in neuroscience and technology are yielding astonishing achievements, particularly in the creation of brain-machine interfaces, neural implants, neuro-modulation tools, and brain-activity feedback systems. These developments are revolutionizing the field of neurotechnology, pushing its potential far beyond conventional limits. Furthermore, brain-machine interfaces enable seamless interactions between the brain and external machines, offering pioneering solutions, especially for individuals with severe mobility impairments or paralysis. Additionally, neural implants are rapidly advancing, restoring lost functions for those affected by injury or illness. Moreover, neuro-modulation devices, including deep brain stimulators, are bringing new promise to conditions like Parkinson's disease and major depression, leading to substantial improvements in patient recovery.

  • Increasing Prevalence of Neurological Disorders:

The surge in neurological conditions like Alzheimer's, Parkinson's, epilepsy, and depression is placing a significant burden on healthcare systems, sparking a growing need for cutting-edge neurotechnological innovations. These debilitating conditions, which affect millions worldwide, pose significant challenges not only to the individuals afflicted but also to their loved ones and the healthcare system as a whole. The intricate nature of these disorders necessitates pioneering solutions for successful management and treatment. Fortunately, neurotechnology holds great promise in this area, offering sophisticated tools for precise diagnosis, continuous monitoring, and targeted treatment. Furthermore, breakthroughs such as advanced imaging technologies, neurotherapeutic devices, and personalized medicine approaches are revolutionizing the care of these conditions, offering new hope for improved well-being, enhanced treatment outcomes, and even potential cures.

  • Rising Investment in Research & Development:

The neurotechnology industry is witnessing a surge in funding for research and development from both government and private sources. This financial support is essential for driving continued innovation and bridging the gap between theoretical breakthroughs in labs and tangible, real-life solutions. Furthermore, investments are opening up new avenues of exploration in neuroscience, leading to the creation of pioneering technologies and treatments that have the potential to revolutionize healthcare. These investments are facilitating the discovery of innovative treatments and diagnostic tools, as well as refining and improving existing neurotechnological devices to make them more efficient, accessible, and user-friendly.

Leading Companies Operating in the Global Neurotechnology Industry:

  • Allengers Medical Systems Ltd
  • Canon Medical Systems Corporation (Canon Inc.)
  • Elekta Solutions AB
  • GE HealthCare Technologies Inc. (General Electric)
  • Koninklijke Philips N.V.
  • Natus Medical Incorporated, Shimadzu Corporation
  • Siemens Healthcare GmbH (Siemens AG)
  • The Magstim Company Limited
  • Tristan Technologies Inc..

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/neurotechnology-market/requestsample

Neurotechnology Market Report Segmentation:

By Product Type:

Product Type Insights:

  • Imaging Modalities 
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Positron Emission Tomography (PET)
  • Neurostimulation 
    • Transcranial Magnetic Stimulation (TMS)
    • Transcranial Direct Current Stimulation (TDCS)
  • Cranial Surface Measurement 
    • Electroencephalography (EEG)
    • Magnetoencephalography (MEG)
  • Neurological Implants

Imaging modalities dominate the market due to their essential role in diagnosing and monitoring neurological disorders, driving demand from healthcare providers and researchers alike. 

By End Users:

End User Insights:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Ambulatory Surgical Centres

Hospitals account for the largest market share owing to the widespread adoption of neurotechnologies to improve patient care and treatment outcomes.

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Global Neurotechnology Market Trends:

Currently, the advancement of brain-computer interfaces is revolutionizing neurotechnology, facilitating seamless interaction between the brain and external devices, with applications in healthcare, gaming, and accessibility. Furthermore, neuroimaging methods, including MRI, EEG, and fNIRS, are becoming increasingly refined, enabling a deeper understanding and visualization of brain function. These techniques are essential in both clinical and research environments. Additionally, neurotechnology is being utilized in healthcare to diagnose, treat, and rehabilitate neurological conditions such as Parkinson's disease, epilepsy, and strokes, incorporating devices that stimulate the brain, modulate neural activity, and provide feedback. Moreover, there is a growing demand for wearable neurodevices that monitor brain activity in real-time, with widespread applications in wellness, athletic performance, and mental health monitoring.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145